CIO Bulletin
| Company | Management | Description |
|---|---|---|
| BlueRock Therapeutics www.bluerocktx.com |
Seth Ettenberg, Ph.D., President & CEO |
BlueRock Therapeutics is pioneering a new era in medicine, transforming stem cell science into restorative therapies that replace damaged cells and restore function. Through innovation, precision, and collaboration, it delivers life-changing solutions to patients worldwide. |
| R3 Stem Cell r3stemcell.com |
David Greene, MD, PhD, MBA, Founder & CEO |
R3 Stem Cell is a global leader in regenerative medicine, delivering safe, personalized, and affordable stem cell and exosome therapies. With 70+ centers worldwide, it transforms lives through innovation, rigorous science, and patient-focused care. |
| Fate Therapeutics www.fatetherapeutics.com |
Bob Valamehr, Ph.D., M.B.A., President & CEO |
Fate Therapeutics revolutionizes off-the-shelf cellular immunotherapies, transforming stem cell science into scalable, precise, and life-changing treatments for cancer and serious diseases. Its iPSC platform enables consistent, safe, and accessible therapies, redefining the future of immuno-oncology worldwide. |
| STEMCELL Technologies www.stemcell.com |
Dr. Allen Eaves, Founder, President & CEO |
STEMCELL Technologies powers global stem cell innovation by providing reliable reagents, advanced tools, and tailored services. Committed to precision, education, and ethical practices, it enables scientists worldwide to accelerate discovery, advance research, and shape the future of medicine. |
| Cells4Life cells4life.com |
Wayne Channon, Chairman |
Cells4Life is the UK’s leading stem cell bank, safeguarding children’s future health through advanced stem cell preservation. Its innovative processing, dual-location storage, and clinical expertise maximize therapeutic potential, empowering families with confidence, foresight, and lifelong medical possibilities. |
Insurance and capital markets
 consultants ltd.jpg)
